Search by Drug Name or NDC
NDC 51754-2150-04 Fentanyl Citrate 50 ug/mL Details
Fentanyl Citrate 50 ug/mL
Fentanyl Citrate is a INTRAVENOUS INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Exela Pharma Sciences, LLC. The primary component is FENTANYL CITRATE.
Product Information
| NDC | 51754-2150 |
|---|---|
| Product ID | 51754-2150_e8e80dc7-fa22-4dff-95d6-299a579fd0a3 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | Fentanyl Citrate |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Fentanyl Citrate |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 50 |
| Active Ingredient Units | ug/mL |
| Substance Name | FENTANYL CITRATE |
| Labeler Name | Exela Pharma Sciences, LLC |
| Pharmaceutical Class | Full Opioid Agonists [MoA], Opioid Agonist [EPC] |
| DEA Schedule | CII |
| Marketing Category | NDA |
| Application Number | NDA215870 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 51754-2150-04 (51754215004)
| NDC Package Code | 51754-2150-4 |
|---|---|
| Billing NDC | 51754215004 |
| Package | 25 VIAL in 1 CARTON (51754-2150-4) / 50 mL in 1 VIAL (51754-2150-1) |
| Marketing Start Date | 2023-05-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |